The immunosuppressive effect of CD8+ Treg lymphocytes is likely to be beneficial by reducing the severity of the inflammatory response present during the development of the graft-versus-host disease (GVHD) or autoimmune diseases. Here, CD8A is linked to autoimmune disease.